 | EyePoint Pharmaceuticals, Inc. | |||
| NGM : EYPT || Location: United States | ||||
$16.47-1.1 (-6.26%) |
1.18 M | 16.22 - 17.85 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 6.845 M |
| March 15, 2024 | 6.579 M |
| Feb. 29, 2024 | 5.724 M |
| Feb. 15, 2024 | 4.750 M |
| Jan. 31, 2024 | 5.135 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.50 | -0.33 | 33.44% |
| 09/30/2023 | -0.52 | -0.33 | 36.91% |
| 06/30/2023 | 0.61 | -0.61 | -199.89% |
| 03/31/2023 | -0.70 | -0.56 | 19.66% |
| 12/31/2022 | -0.62 | -1.16 | -86.44% |
EYPT Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 49.831M | Shares Float | 30.745M |
| Short Float | 6.845M | Market Cap | 875.53M |
| Institution ownership | 0.00% | Insider ownership | 1.022% |
| Earnings Date | 05/01/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.82 | Forward EPS | -2.53 |